We are hiring! Spector Partners is hiring for an associate! We are a Philadelphia-based plaintiffs’ class action firm with practices in antitrust, privacy and consumer protection litigation. We are looking for a lawyer with up to three years of experience to assist in research, briefing and discovery projects. The ideal […]

Spector Partners Appointed Co-Lead Counsel in Da Vinci Surgical Robot Litigation Spector Partners has been appointed as interim Co-Lead Counsel for direct purchaser plaintiffs in an antitrust action against Intuitive Surgical, Inc. The claim against Intuitive alleges that the company’s monopoly position forces hospitals to buy its maintenance services and replacement

Spector Partners Partner Tapped to Lead Data Privacy Litigation Diana Zinser has been appointed as Co-Lead Counsel in Frasco et al. v. Flo Health, Inc., et al., a data privacy class action. Plaintiffs who used the popular ovulation- and period-tracking Flo App allege that its creator, Flo Health Inc., unlawfully divulged users’

Spector Partners Appointed to Xyrem Leadership Team Spector Partners partner John Macoretta has been appointed to the Plaintiffs’ Steering Committee in the In Re Xyrem (Sodium Oxydate) Antitrust Litigation. This multi-district litigation is overseen by Judge Lucy Koh in the Northern District of California. The Plaintiffs, including SRK’s client, allege that Jazz Pharmaceuticals made baseless patent infringement claims

Recent Drug Suppression Cases Bystolic (nebivolol HCL)AbbVie’s blood pressure drug, Bystolic, accountsfor nearly $1 billion in yearly US sales. In December2011, manufacturers began applying to market genericversions of Bystolic. AbbVie’s subsidiary, Forest, sued those manufacturers for patent infringement. Such lawsuits cause an automatic stay of FDA approvals, meaning a generic version

Juneteenth In order to honor Juneteenth and recognize its importance in our nation’s continuing quest for legal and economic justice for all, Spector Partners has designated June 19th as an annual firm holiday.

$65M in settlements approved in Provigil litigation Provigil Litigation Settlements Given Final Approval More than $65 million in settlements have just been given final approval in the long-running litigation over the drug Provigil and its generic versions (modafinil).  The settlements are between all of the defendants and a class of

In the News: Judge Approves $22M for End-Payer Attorneys in Provigil Litigation The federal judge overseeing the Provigil antitrust litigation has awarded attorneys representing end-payers nearly $22 million in fees. U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania on Tuesday awarded $21.9 million to leading attorneys representing the group of consumers

Spector Partners sues Wawa over months-long Data Breach In January, Spector Partners filed a class action against Wawa on behalf of customers who used credit or debit cards at Wawa between March and December 2019. On December 19, 2019 Wawa revealed it had experienced a months-long data breach that compromised

Spector Partners and Coronavirus Spector Partners has temporarily closed its office. Although we are not physically in our office, we are “at work.” Our attorneys and staff are working remotely and are available to answer any questions you have about legal matters or other matters related to the current health